1. Home
  2. PROK vs QMCO Comparison

PROK vs QMCO Comparison

Compare PROK & QMCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PROK
  • QMCO
  • Stock Information
  • Founded
  • PROK 2015
  • QMCO 1980
  • Country
  • PROK United States
  • QMCO United States
  • Employees
  • PROK N/A
  • QMCO N/A
  • Industry
  • PROK Biotechnology: Biological Products (No Diagnostic Substances)
  • QMCO Electronic Components
  • Sector
  • PROK Health Care
  • QMCO Technology
  • Exchange
  • PROK Nasdaq
  • QMCO Nasdaq
  • Market Cap
  • PROK 126.8M
  • QMCO 123.4M
  • IPO Year
  • PROK N/A
  • QMCO N/A
  • Fundamental
  • Price
  • PROK $0.60
  • QMCO $11.11
  • Analyst Decision
  • PROK Buy
  • QMCO Hold
  • Analyst Count
  • PROK 4
  • QMCO 3
  • Target Price
  • PROK $5.00
  • QMCO $19.00
  • AVG Volume (30 Days)
  • PROK 410.9K
  • QMCO 2.1M
  • Earning Date
  • PROK 05-09-2025
  • QMCO 02-12-2025
  • Dividend Yield
  • PROK N/A
  • QMCO N/A
  • EPS Growth
  • PROK N/A
  • QMCO N/A
  • EPS
  • PROK N/A
  • QMCO N/A
  • Revenue
  • PROK $76,000.00
  • QMCO $285,865,000.00
  • Revenue This Year
  • PROK N/A
  • QMCO N/A
  • Revenue Next Year
  • PROK N/A
  • QMCO $2.46
  • P/E Ratio
  • PROK N/A
  • QMCO N/A
  • Revenue Growth
  • PROK N/A
  • QMCO N/A
  • 52 Week Low
  • PROK $0.68
  • QMCO $2.22
  • 52 Week High
  • PROK $4.44
  • QMCO $90.64
  • Technical
  • Relative Strength Index (RSI)
  • PROK 21.04
  • QMCO 38.04
  • Support Level
  • PROK $0.87
  • QMCO $12.85
  • Resistance Level
  • PROK $1.00
  • QMCO $15.30
  • Average True Range (ATR)
  • PROK 0.10
  • QMCO 2.38
  • MACD
  • PROK -0.01
  • QMCO -0.23
  • Stochastic Oscillator
  • PROK 3.98
  • QMCO 2.70

About PROK ProKidney Corp.

ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's own cells isolated from the patient intended for treatment. Its lead product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's own renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of development program for severe diabetic kidney disease.

About QMCO Quantum Corporation

Quantum Corp is a United States-based company that delivers end-to-end data management solutions designed for unstructured data. The company provides solutions for the entire data lifecycle. The company specialize in solutions for video, images, audio, and other large files. The company's portfolio of products includes primary storage software and systems, secondary storage software and systems, as well as devices and media. The company's Primary Storage Software and Systems include Myriad All-Flash Software-Defined Storage, StorNext Hybrid Flash/Disk File Storage Software, and Unified Surveillance Platform Software. Secondary Storage Software and Systems include ActiveScale Object Storage Software and DXi Backup Appliances. The firm derives the majority of its revenue from United States.

Share on Social Networks: